Orthofix price target hits $36 — 5 key updates

Zacks updated Orthofix’s price target to $36, according to a Legacy report.

Advertisement

Here are five quick updates:

 

• Orthofix was given a consensus broker rating of “strong buy” from two covering companies.
• Orthofix has an industry rank of 150 out of 265 based on the competitors’ ratings.
• TheStreet upgraded Orthofix to “buy” from “hold” last week.
• Market cap is $707.96 million.
• The stock price opened at $37.75 today.

 

More articles on orthopedic devices:
16 spine devices receive FDA 510(k) clearance in March
Zimmer voluntarily recalls knee devices
5 key trends in the global non-fusion spinal device market

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.